| abstract |
The present application relates to novel substituted 2-(piperidin-1- yl)acetamide derivatives of the formula (I) in which A is an optionally substituted or fused piperidine ring of the formula (I‑a) or (I‑b), to processes for preparation thereof, to the use thereof for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of cardiovascular disorders. |